Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 12
Submit an article Journal homepage
449
Views
19
CrossRef citations to date
0
Altmetric
Original Article: Clinical

Role of rituximab in treatment of patients with primary central nervous system lymphoma: a retrospective analysis of the Czech lymphoma study group registry

Heidi MocikovaDepartment for Internal Medicine and Haematology, Faculty Hospital Kralovske Vinohrady and Third Faculty of Medicine, Charles University in Prague, Czech Republic; Correspondence[email protected]
,
Robert PytlikFirst Medical Department – Clinical Department of Haemato-oncology, First Faculty of Medicine and General Teaching Hospital, Charles University in Prague, Czech Republic;
,
Alice SykorovaFourth Department of Internal Medicine – Hematology, Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic;
,
Andrea JanikovaDepartment of Internal Medicine and Hemato-oncology, University Hospital, Brno, Czech Republic;
,
Vit ProchazkaDepartment of Hemato-oncology, Faculty of Medicine and Dentistry, Palacky University and University Hospital Olomouc, Czech Republic;
,
Samuel VokurkaDepartment of Hemato-oncology, University Hospital, Pilsen, Czech Republic;
,
Adela BerkovaFirst Medical Department – Clinical Department of Haemato-oncology, First Faculty of Medicine and General Teaching Hospital, Charles University in Prague, Czech Republic;
,
David BeladaFourth Department of Internal Medicine – Hematology, Charles University Hospital and Faculty of Medicine, Hradec Kralove, Czech Republic;
,
Vit CamprInstitute of Pathology and Molecular Medicine, Second Faculty of Medicine, Charles University in Prague, Czech Republic;
,
Lucie BuresovaDSC Services, S.R.O, Tisnov, Czech Republic
,
Marek TrnenyFirst Medical Department – Clinical Department of Haemato-oncology, First Faculty of Medicine and General Teaching Hospital, Charles University in Prague, Czech Republic;
& on behalf of Czech Lymphoma Study Group show all
Pages 2777-2783 | Received 10 Nov 2015, Accepted 13 Mar 2016, Published online: 18 Apr 2016

Citations (19)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Matthias Holdhoff, Nina Wagner-Johnston & Mark Roschewski. (2020) Systemic Approach to Recurrent Primary CNS Lymphoma: Perspective on Current and Emerging Treatment Strategies. OncoTargets and Therapy 13, pages 8323-8335.
Read now
Ning-ning Hu, Man-man Zhang, Yan-yan Chen & Bei-lei Zhu. (2019) Primary central nervous system lymphoma with no enhancement initially and no significant progression over a long term: a case report and review of the literature. International Journal of Neuroscience 129:3, pages 303-307.
Read now
Henry Chan, Fabio Ynoe Moraes, Alejandro Berlin, Michael Crump, Warren Mason, Normand Laperriere, John Kuruvilla & Anca Prica. (2019) Significance of treatment response when managing patients with primary central nervous system lymphoma. Leukemia & Lymphoma 60:2, pages 349-357.
Read now
Gunilla Enblad, Gustaf Martinsson, Eva Baecklund, Göran Hesselager, Christer Sundström, Rosie-Marie Amini & Hans Hagberg. (2017) Population-based experience on primary central nervous system lymphoma 2000–2012: the incidence is increasing. Acta Oncologica 56:4, pages 599-607.
Read now

Articles from other publishers (15)

Yuhang Zhang, Zhihe Liu, Chengwen Gao, Haiyan Bian, Yushuo Ma, Fanjing Jing & Xia Zhao. (2023) Role of Rituximab in Treatment of Patients With Primary Central Nervous System Lymphoma (PCNSL): A Systematic Review and Meta-Analysis. Clinical Lymphoma Myeloma and Leukemia.
Crossref
Ruben Van Dijck, Jeanette K. Doorduijn & Jacoline E.C. Bromberg. (2021) The Role of Rituximab in the Treatment of Primary Central Nervous System Lymphoma. Cancers 13:8, pages 1920.
Crossref
Alexander C. Mohler & Douglas E. Ney. 2021. Neuroimmunology. Neuroimmunology 417 430 .
Hua Yang, Yang Xun, Anping Yang, Fang Liu & Hua You. (2020) Advances and challenges in the treatment of primary central nervous system lymphoma. Journal of Cellular Physiology 235:12, pages 9143-9165.
Crossref
Jacoline E. C. Bromberg, Matthijs van der Meulen & Jeanette K. Doorduijn. (2020) The Role of Rituximab in Primary Central Nervous System Lymphoma. Current Oncology Reports 22:8.
Crossref
Andrea Jirkuvová, Vít Procházka & Aleš Obr. (2020) Current perspective on diagnosis and treatment of primary central nervous system lymphomas. Onkologie 14:3, pages 110-113.
Crossref
Carlos Eduardo Correia, Lauren R. Schaff & Christian Grommes. (2020) Central Nervous System Lymphoma. The Cancer Journal 26:3, pages 241-252.
Crossref
Cui Chen, Peng Sun, Juan Cui, Shumei Yan, Hao Chen, Yi Xia, Xiwen Bi, Panpan Liu, Yu Wang, Hang Yang, Man Nie, Xue‐Wen Zhang, Wenqi Jiang & Zhi‐Ming Li. (2019) High‐dose Methotrexate plus temozolomide with or without rituximab in patients with untreated primary central nervous system lymphoma: A retrospective study from China. Cancer Medicine 8:4, pages 1359-1367.
Crossref
Mukesh Patekar, Narayan Adhikari, Ahitagni Biswas, Vinod Raina, Lalit Kumar, Bidhu Kalyan Mohanti, Ajay Gogia, Atul Sharma, Atul Batra, Sameer Bakhshi, Ajay Garg, Sanjay Thulkar, Meher Chand Sharma, Sreenivas Vishnubhatla, Saphalta Baghmar & Ranjit Kumar Sahoo. (2019) Primary CNS Lymphoma in India: A 17-Year Experience From the All India Institute of Medical Sciences. Journal of Global Oncology:5, pages 1-9.
Crossref
Lauren R. Schaff & Christian Grommes. (2018) Updates on Primary Central Nervous System Lymphoma. Current Oncology Reports 20:2.
Crossref
Xiao Han, Yali Ji, Mingqi Ouyang, Tienan Zhu & Daobin Zhou. (2017) Efficacy and safety of HD-MTX based systemic chemotherapy regimens: retrospective study of induction therapy for primary central nervous system lymphoma in Chinese. Scientific Reports 7:1.
Crossref
Louis Royer-Perron, Khê Hoang-Xuan & Agusti Alentorn. (2017) Primary central nervous system lymphoma: time for diagnostic biomarkers and biotherapies?. Current Opinion in Neurology 30:6, pages 669-676.
Crossref
Yue Song, Yibo Wen, Weili Xue, Yanjie Zhang & Mingzhi Zhang. (2017) Effect of rituximab on primary central nervous system lymphoma: a meta-analysis. International Journal of Hematology 106:5, pages 612-621.
Crossref
Ni Fan, Lu Zhang, Xiaoping Xu, Bobin Chen, Chen Zhu, Pei Li, Zi Chen, Tianling Ding, Yan Ma, Yan Yuan & Zhiguang Lin. (2017) Methotrexate plus idarubicin improves outcome of patients with primary central nervous system lymphoma. Oncotarget 8:32, pages 53701-53713.
Crossref
Xuefei Sun, Jing Liu, Yaming Wang, Xueyan Bai, Yuedan Chen, Jun Qian, Hong Zhu, Fusheng Liu, Xiaoguang Qiu, Shengjun Sun, Nan Ji & Yuanbo Liu. (2017) Methotrexate-cytarabine-dexamethasone combination chemotherapy with or without rituximab in patients with primary central nervous system lymphoma. Oncotarget 8:30, pages 49156-49164.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.